Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2Other neoplasm 1Lymphoid 1Breast 1

Conditions

Malignant Neoplasms of Digestive Organs 1

Interventions

Surveys and Questionnaires 3toripalimab 1sapanisertib 1iodixanol 1durvalumab 1daratumumab 1abemaciclib 1Yogurt 1Tomography, Optical Coherence 1Polyvinyl Alcohol 1Medicine, Chinese Traditional 1MLN 8237 1Iodized Oil 1Immunohistochemistry 1Ethiodized Oil 1Electrocardiography, Ambulatory 1Celecoxib 1Aromatase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × sapanisertib × Other neoplasm × Clear all
NCT02812056 2017-03-27

Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated Malignancies

M.D. Anderson Cancer Center

Phase 1 Withdrawn
Other neoplasm

Malignant Neoplasms of Digestive Organs

Data powered by HemOnc (CC BY 4.0) Colophon âš¡